Long-Term Outcomes Following Trabeculectomy Combined with 25-Gauge Transconjunctival Sutureless Vitrectomy in Uveitis Patients. (June 2015)

• Record Type: Journal Article
• Authors: Kim, Bo Hyuck; Shin, Joo Young; Lee, Min Joung; Kim, Suk Hwan; Yu, Hyeong Gon
• Is Part Of: Ocular immunology and inflammation. Volume 23:Number 3(2015)
• Page Start: 212
• Page End: 218
• Publication Date: 2015-06
• Subjects: Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.3109/09273948.2014.892626
• Languages: English
• ISSNs: 0927-3948

Abstract

<abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: To evaluate the efficacy of combined trabeculectomy (TLE) and 25-gauge transconjunctival sutureless vitrectomy (TSV-25) for uveitis patients.</p> <p> <italic>Methods</italic>: Combined TSV-25/TLE was performed in 9 eyes of 6 patients with vitreoretinal complications and intractable glaucoma. Visual acuity, intraocular pressure (IOP), inflammatory control, and number of hypotensive medications were evaluated.</p> <p> <italic>Results</italic>: Visual acuity improved in 7 of 9 eyes and inflammation was controlled with a decreased oral anti-inflammatory agent dosage in all eyes. Mean IOP, which was 28.11 ± 4.83 mmHg preoperatively, was significantly reduced (15.77 ± 2.68 mmHg) 5 years after surgery (<italic>p</italic> = 0.008). The mean number of IOP-lowering medications was 3.33 ± 0.71 before surgery and 1.11 ± 0.92 5 years after surgery (<italic>p</italic> = 0.007). Two eyes required implant of an Ahmed drainage valve during the follow-up period.</p> <p> <italic>Conclusion</italic>: Combined TSV-25/TLE can be effective in managing vitreoretinal complications and elevated IOP in uveitis patients.</p> </abstract>